9 hours ago My Profile. Name Date of Birth Address Email Mobile. View / Edit Profile. ... *Email (Your Email is your Portal Username) *Zip Code. Send service updates and medication reminders to the above email. ... Please call 1-800-222-6885 to speak confidentially with a patient assistance counselor. >> Go To The Portal
My Profile. Name Date of Birth Address Email Mobile. View / Edit Profile. ... *Email (Your Email is your Portal Username) *Zip Code. Send service updates and medication reminders to the above email. ... Please call 1-800-222-6885 to speak confidentially with a patient assistance counselor.
Use your AbbVie Active Directory network credentials to sign-in. If you need assistance, please contact the Global Service Desk at +1 800 252-4415 (USA toll free), +1 847 938-1234 (Outside the US) or your regional Global Service Desk.
AbbVie has carefully designed its benefit programs with your needs in mind. The browser you are currently using is not supported by this website. The website works best when your internet browser is Internet Explorer 11 or one of the two most recent major (non-beta) versions of Chrome, Edge, Firefox or Safari.
Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.
If you have any questions, visit the FAQs or call us at 1-800-222-6885. AbbVie is committed to helping patients get the medicines they need. That’s why we offer patient assistance programs that provide free AbbVie medicines to qualifying patients.
myAbbVie Assist. We believe that people who need our medicines should be able to get them. That’s why myAbbVie Assist provides free AbbVie medicine to qualifying patients . If you have any questions, visit the FAQs or call us at 1-800-222-6885. AbbVie is committed to helping patients get the medicines they need.
It is free to apply, and those who qualify will receive their medicine for free — no co-pays or shipping costs. This program supports patients who: Are being treated by a licensed U.S. healthcare provider on an outpatient basis and prescribed an AbbVie medicine that is included in our assistance program.
Symptoms related to TB include a cough, low-grade fever, weight loss, or loss of body fat and muscle. Hepatitis B infection in carriers of the virus.
Tell your doctor about all of your health conditions, including if you: Have an infection, are being treated for infection, or have symptoms of an infection. Get a lot of infections or infections that keep coming back. Have diabetes.
Moderate to severe rheumatoid arthritis (RA) in adults. HUMIRA can be used alone, with methotrexate, or with certain other medicines. HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities.
Symptoms of a serious allergic reaction include hives, trouble breathing, and swelling of your face, eyes, lips, or mouth. Nervous system problems. Signs and symptoms include numbness or tingling, problems with your vision, weakness in your arms or legs, and dizziness.
HUMIRA can be used alone or with certain other medicines. HUMIRA may prevent further damage to your bones and joints and may help your ability to perform daily activities. Ankylosing spondylitis (AS) in adults. Moderate to severe hidradenitis suppurativa (HS) in people 12 years and older.
Moderate to severe hidradenitis suppurativa (HS) in people 12 years and older. To treat moderate to severe Crohn’s disease (CD) in adults and children 6 years of age and older. To treat moderate to severe ulcerative colitis (UC) in adults and children 5 years of age and older.
Cancer. For children and adults taking TNF blockers, including HUMIRA, the chance of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma.